MAPT and Alzheimer disease: Cathepsin D (CatD) is a lysosomal aspartyl protease that degrades both Aβ [7, 8] and tau [9] in vitro and is strongly implicated in the pathogenesis of AD and multiple other neurodegenerative diseases [10].